RE: Multibillion company24 Apr 2020 11:23
when in around 11 weeks ncyt manufacturing approximatley 8 million tests month
taken from last weeks rns released 15 minutes before end of trading ,like how many late in trading day rns ncyt release
Wed, 15th Apr 2020 16:15
Further to the announcement on 30 March 2020, Primerdesign has now achieved the target run-rate of manufacturing its COVID-19 test at a rate of four million tests per month. To continue to meet demand, the Company is working to further increase this manufacturing capacity and has signed manufacturing partnership agreements with BioPharma Process Services Ltd and Biofortuna Limited, both based in the UK, to support its existing partnership agreements. In addition, Novacyt continues to scale-up its own production at its Primerdesign site in Southampton, UK. With this additional capacity, the Company expects, over the next three months, to increase production of the test to approximately eight million tests per month.